Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Eating Well (or at Least Not terribly) at Fast Food Resturants
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Type 2 Medications Articles

Drug Combo Slows Onset of Type 2 Diabetes
Vitamin D May Reduce Risk for Type 2
Tradjenta, a Drug for Type 2s, Now on U.S. Market
Looking at Cannabis Based Type 2 Treatment
Type 2 Profile: Tony Flores
Keeping the Weight Off: An Interview with Ellen Granberg, PhD
A New Kind of Pharmacist
Need Medicine and Have No Insurance for Your Diabetes?
Flushing Away High Blood Sugar
Walgreens in South Florida and Diabetes Research Institute Foundation Announce Unique Partnership
Diabetes Health Reference Charts
Type 2 Medications (PDF)
Type 2 Meds Reference Guide (PDF)
See All Charts…
Type 2 Medications Archives
Browse the Type 2 Medications Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (1)

Type 2 Diabetes and Simvastatin


Jun 1, 2004

Not Just Cholesterol-Lowing Benefits

A South Carolina study indicates that simvastatin (Zocor), an oral “statin” lipid-lowering drug is a potentially beneficial treatment for the inflammatory reaction associated with atherosclerosis.

Twenty-six patients with type 2 diabetes participated in the study. They were started on a lipid-lowering diet and encouraged to exercise in addition to receiving Zocor treatment that was adjusted until LDL cholesterol levels reached 100 mg/dl or lower.

A1C levels remained constant throughout the study. There was a highly significant reduction in blood levels of immune complexes containing modified lipoproteins after three to six months of treatment with Zocor.

Levels returned to baseline after Zocor use was discontinued.

Researchers note this may represent an additional mechanism for the reduced incidence of cardiovascular events in patients treated with Zocor.

—Diabetes Care, April 2004

Categories: A1c Test, Diabetes, Diabetes, Lipid Problems, Other Lab Tests, Research, Type 2 Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 1 comment - Jun 1, 2004

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.